Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/11/1999CA2496859A1 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
11/11/1999CA2331863A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament
11/11/1999CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999CA2331801A1 Method of hsv prophylaxis
11/11/1999CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999CA2331122A1 Hematopoietic stimulation
11/11/1999CA2331070A1 New use
11/11/1999CA2331042A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999CA2331041A1 Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2331036A1 Spla2 inhibitor ester
11/11/1999CA2330856A1 Spla2 inhibitor compounds for treatment of disease
11/11/1999CA2330811A1 Monomeric, oligomeric and polymeric knoevenagel condensation products
11/11/1999CA2330738A1 Novel n-oxides of benzonaphthyridines
11/11/1999CA2330641A1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same
11/11/1999CA2330568A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
11/11/1999CA2330388A1 Compounds having glucuronic acid derivative and glucosamine derivative in structure thereof, method for producing the compounds, and uses of the compounds
11/11/1999CA2330049A1 Hydroxyomeprazole compositions and uses
11/11/1999CA2329925A1 Desmethylpantoprazole compositions and methods
11/11/1999CA2329736A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations
11/11/1999CA2329704A1 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328732A1 Biphenyl derivatives
11/11/1999CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
11/11/1999CA2327543A1 Method of treating bladder and lower urinary tract syndromes
11/11/1999CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999CA2326763A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and methods for their synthesis
11/11/1999CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999CA2295510A1 Use of a nuclease inhibitor or interleukin-10 (il-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy
11/11/1999CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955545A1 Process to select bacterial strains
11/10/1999EP0955314A2 Peptide analogues of glucagon-like-peptide-1 (7-37), their preparation and pharmaceutical compositions
11/10/1999EP0955307A1 Erythromycin a derivatives and methods for the preparation thereof
11/10/1999EP0955301A2 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
11/10/1999EP0955299A1 Benzothiophene, benzofurane and indole derivatives, process for their preparation and pharmaceutical compositions containing them
11/10/1999EP0955296A2 Tertiary alkyl functionalized piperazine derivatives
11/10/1999EP0955295A1 Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
11/10/1999EP0955294A2 Imidazolyl-alkenoic acid
11/10/1999EP0955286A1 Dihydro- or tetrahydronaphthalene derivatives having (anti-)estrogen activity
11/10/1999EP0955065A1 Polyethylene glycol (PEG 4000) in a contrast medium composition for echography
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955055A2 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient
11/10/1999EP0955052A1 Arsenic hexaoxide (As4O6) for use in cancer therapy and its pharmaceutical composition
11/10/1999EP0955051A1 Composition containing procyanidolic oligomerides and a divalent cation
11/10/1999EP0955050A1 Agent for anti-oseoporosis
11/10/1999EP0955049A2 6 Beta-Hydroxy - 6 alpha, 17 alpha - dimethylpregn - 4 ene - 3,20 - dione, as an inhibitor of smooth muscle proliferation
11/10/1999EP0955047A2 Use of conjugated linoleic acids to modify platelet function
11/10/1999EP0955045A1 Drugs for improving ocular circulation disorders
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0955043A2 Anti-cellulite pantyhose
11/10/1999EP0955042A1 Pharmaceutical composition of estrogen and progesteron
11/10/1999EP0955040A1 Oral composition comprising mesna
11/10/1999EP0954983A2 Methods of using isomer enriched conjugated linoleic acid compositions
11/10/1999EP0954975A2 Isomer enriched conjugated linoleic acid compositions
11/10/1999EP0954594A2 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages
11/10/1999EP0954591A2 Mini-adenoviral vector
11/10/1999EP0954585A2 Human telomerase catalytic subunit
11/10/1999EP0954582A1 Polynucleotide vaccine against canine distemper
11/10/1999EP0954578A1 Glycoprotein hormone superagonists
11/10/1999EP0954576A2 Cd16-ii variants
11/10/1999EP0954573A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
11/10/1999EP0954565A1 Adipogenic differentiation of human mesenchymal stem cells
11/10/1999EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999EP0954530A1 Immunomodulatory peptides of vespid antigen 5
11/10/1999EP0954526A2 Serine protease inhibitors
11/10/1999EP0954525A1 Novel compounds
11/10/1999EP0954521A1 4- (thien-3-yl)methyl] imidazole derivatives having alpha2-adrenoceptor agonistic activity
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954340A1 Targeted combination immunotherapy of cancer
11/10/1999EP0954339A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954337A1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/10/1999EP0954336A2 Membrane incorporation of texaphyrins
11/10/1999EP0954334A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
11/10/1999EP0954333A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/10/1999EP0954331A1 Novel compounds
11/10/1999EP0954330A1 Intestinal trefoil proteins
11/10/1999EP0954329A1 Method of killing target cells in harvested cell populations with one or more immunotoxins
11/10/1999EP0954327A1 Useful formulations of acid addition salt drugs
11/10/1999EP0954324A1 Cyclic peptide vaccines for treatment and prevention of diabetes
11/10/1999EP0954323A1 Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
11/10/1999EP0954322A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition
11/10/1999EP0954321A1 Synergistic gold-containing compositions
11/10/1999EP0954320A1 Inositol polyphosphate derivatives and methods of using same
11/10/1999EP0954319A1 Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
11/10/1999EP0954318A1 A nasal spray containing an intranasal steroid and an antihistamine
11/10/1999EP0954317A2 Use of 7 apha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
11/10/1999EP0954315A2 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
11/10/1999EP0954314A1 Dosage forms and method for ameliorating male erectile dysfunction
11/10/1999EP0954313A1 Method for treating tumors having high ldl requirements employing mtp inhibitors
11/10/1999EP0954312A1 Topical composition for burn healing
11/10/1999EP0954311A1 Use of 1- 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl) ethane for preparing medicines for the treatment of cerebral and neuronal disorders
11/10/1999EP0954310A1 Synergistic composition comprising rapamycin and calcitriol
11/10/1999EP0954309A1 Hiv and cancer treatment
11/10/1999EP0954308A1 Therapeutic treatment for cardiovascular diseases
11/10/1999EP0954307A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
11/10/1999EP0954306A1 Methods of increasing nitric oxide synthesis
11/10/1999EP0954305A2 Use of carbonic anhydrase inhibitors for treating macular edema
11/10/1999EP0954304A2 Methods for regulating nicotine metabolism
1 ... 6414 6415 6416 6417 6418 6419 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 ... 7860